New hope for the millions of people who suffer from migraines.
Two new drug studies could change the way they are treated.
“We’ve identified a new preventive treatment for migraines, something that reduces frequency, the number of attacks and severity of attacks, how bad the attacks are,” said Dr. Peter Goadsby, co-author of both studies and professor of neurology at Kings College, London and the University of California, San Francisco. “The results herald a new mechanism for the preventive treatment of migraines.”
Both drugs aim to prevent migraines from occurring in the first place.
In trails patients who received the medications had fewer migraines.
The other promising drug is called LY2951742. It too was found to be a safe and effective migraine treatment. In that study, 217 patients who had migraines 4 to 14 days per month got a 150 mg injection of LY2951742 every two weeks for 12 weeks. Those who got the shots saw about a 4-day reduction (or 63%) in the number of days with migraines, compared to a 42% decrease for those who got the placebo.
The drugs still need to be tested in large-scale clinical trials, and receive FDA approval, before patients can access them.
Researchers estimate that’s at least three years away.